Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)

• Unité de recherche: INNOSUISSE
• Numéro de projet: 62799.1 IP-LS
• Titre du projet anglais: Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)

Description succincte (Allemand)

Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)

Description succincte (Anglais)

Targeting immunosenescence post cancer by boosting metabolic health

Résumé des résultats (Abstract) (Allemand)

Amazentis has discovered a novel nutrient that improves immune function by boosting mitochondrial health. These findings are applicable for cancer survivors with a weak immune system. A study with leading oncologists at CHUV is proposed to translate and commercialize an advanced nutrition product.